Showing results (171-180 of 876) with videos related to
Sort By:
Pageof 88
Journal of Molecular Biology|November 13, 1998
Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpartG M Cheetham, G Hale, H Waldmann, et al.Biomaterials|July 1, 1988
Simulation of vascular surfaces: differential saturation with glycosaminoglycans and their quantitative analysisG Hale, A C Hann, F S Wusteman, et al.Msphere|August 28, 2020
Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic PotentialEva E Spieler, Eva Moritz, Silke Stertz, et al.The Journal of General Virology|September 18, 2008
The multifunctional NS1 protein of influenza A virusesBenjamin G Hale, Richard E Randall, Juan Ortín, et al.Clinical Dysmorphology|September 6, 2007
MURCS and thenar hypoplasiaR J McKinlay Gardner, Mark P Umstad, Lyndon G HaleProgress in Clinical and Biological Research|January 1, 1990
Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanismsS P Cobbold, G Hale, M R Clark, et al.Cytotherapy|October 30, 2004
Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasiaN Novitzky, V Thomas, H Stubbings, et al.The Biochemical Journal|December 1, 1981
Lipoic acid residues in a take-over mechanism for the pyruvate dehydrogenase multienzyme complex of Escherichia coliJ N Berman, G X Chen, G Hale, et al.The Journal of Rheumatology|November 1, 1991
Humanized monoclonal antibody treatment in rheumatoid arthritisV Kyle, J Roddy, G Hale, et al.Journal of Virology|September 21, 2012
Contribution of NS1 effector domain dimerization to influenza A virus replication and virulenceJuan Ayllon, Rupert J Russell, Adolfo García-Sastre, et al.Pageof 88